サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566936

自動免疫測定装置市場：製品別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年

Automatic Immunoassay Analyzer Market By Product , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 228 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
自動免疫測定装置市場：製品別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 228 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

自動免疫測定装置市場は、2023年に123億米ドルと評価され、2024年から2033年にかけてCAGR 15.3％で成長し、2033年には514億米ドルに達すると予測されています。

自動免疫測定装置は、抗原抗体反応を利用して免疫測定を行い、生体試料中のタンパク質、ホルモン、薬物などの物質を検出・定量する高度な医療機器です。サンプル調製から結果の解釈までの全プロセスを自動化することで、臨床・研究現場における効率性、正確性、スループットを向上させます。診断検査室、病院、製薬業界で広く使用され、信頼性が高く一貫性のある結果を提供することで、患者の治療や調査結果のスピードと質を向上させています。

自動免疫測定装置の世界市場の成長は、がん、心血管疾患、糖尿病などの慢性疾患の憂慮すべき有病率の上昇が主な要因であり、頻繁で正確な診断検査が必要です。世界保健機関（WHO）が2023年9月に発表した調査によると、心血管疾患は最も蔓延している慢性疾患の一つで、年間1,790万人が死亡しており、次いでがんが約930万人、糖尿病による腎臓病死を含む糖尿病が200万人となっています。さらに、老年人口の増加が市場成長に大きく寄与しています。これは、人口の高齢化に伴い、加齢関連疾患を監視・管理するための診断検査に対する需要が増加し、自動免疫測定装置市場を押し上げているためです。世界保健機関（WHO）によると、60歳以上の高齢者数は2019年に10億人に達しました。この数は2030年には14億人、2050年には21億人に増加すると推定されています。高齢者人口の増加に伴い、慢性疾患の発生率は大幅に上昇すると予想されます。さらに、疾病の早期発見と予防ヘルスケアの重要性に対する意識の高まりが、診断検査の利用増加につながり、自動免疫測定装置の需要を押し上げています。正確でタイムリーな診断情報を必要とする個別化医療への動向の高まりは、信頼性が高く高スループットの免疫測定システムへの需要をさらに加速しています。しかし、高度な免疫分析装置には初期投資とメンテナンスコストがかかり、定期的なメンテナンス、校正、技術サポートが必要なことが市場の成長を抑制しています。さらに、多くの国では国民のニーズを満たす適切な医療施設がなく、アクセスが限られていることも、市場の主な阻害要因となっています。その一方で、免疫測定分析装置をデジタルヘルスプラットフォームや電子カルテと統合してデータ管理を合理化し、検査室のワークフロー全体の効率を向上させる傾向が強まっており、予測期間中の市場成長に有利な機会を提供すると期待されています。さらに、メーカーは1つのサンプルから複数のバイオマーカーを同時に測定できるマルチプレックスイムノアッセイの開発に注力しています。このような市場開拓により、今後数年間で市場成長の新たな道が開かれるものと期待されます。

自動免疫測定装置の世界市場は、製品、アプリケーション、エンドユーザー、地域に区分されます。製品別では、免疫蛍光、化学発光、酵素連結蛍光システム、その他に分類されます。アプリケーション別では、感染症、内分泌、薬剤モニタリング、慢性疾患、アレルギー検査、その他に分類されます。エンドユーザー別では、病院、診断ラボ、製薬・バイオテクノロジー企業、その他に分けられます。地域別では、北米、欧州、アジア太平洋、LAMEAで分析されています。

主な調査結果

製品別では、化学発光セグメントが2024年から2033年にかけて市場を独占すると予測されます。

アプリケーション別では、感染症セグメントが2023年の主要株主でした。

エンドユーザー別では、製薬・バイオテクノロジー企業セグメントが自動免疫測定装置市場で今後数年間に大きな成長を遂げるとみられます。

地域別では、自動免疫測定装置は近い将来、北米で高い注目を集めそうです。

本レポートのカスタマイズが可能です。

  • 規制ガイドライン
  • クライアントの関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • 主要プレーヤーの詳細（所在地、連絡先、サプライヤー／ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 自動免疫測定装置市場：製品別

  • 市場概要
  • 免疫蛍光
  • 化学発光
  • 酵素連動蛍光システム
  • その他

第5章 自動免疫測定装置市場：用途別

  • 市場概要
  • 感染症
  • 内分泌学
  • 薬剤モニタリング
  • 慢性疾患
  • アレルギー検査
  • その他

第6章 自動免疫検査装置市場：エンドユーザー別

  • 市場概要
  • 病院
  • 診断研究所
  • 製薬・バイオテクノロジー企業
  • その他

第7章 自動免疫検査装置市場：地域別

  • 市場概要
  • 北米
    • 主な市場動向と機会
    • 米国の自動免疫測定装置市場
    • カナダ自動免疫測定装置市場
    • メキシコ自動免疫測定装置市場
  • 欧州
    • 主要市場動向と機会
    • ドイツの自動免疫測定装置市場
    • フランスの自動免疫測定装置市場
    • 英国の自動免疫測定装置市場
    • イタリア自動免疫測定装置市場
    • スペイン自動免疫測定装置市場
    • その他欧州の自動免疫測定装置市場
  • アジア太平洋
    • 主な市場動向と機会
    • 日本の自動免疫測定装置市場
    • 中国の自動免疫測定装置市場
    • インドの自動免疫測定装置市場
    • オーストラリアの自動免疫測定装置市場
    • 韓国の自動免疫測定装置市場
    • その他アジア太平洋の自動免疫測定装置市場
  • ラテンアメリカ・中東・アフリカ
    • 主な市場動向と機会
    • ブラジル自動免疫測定装置市場
    • サウジアラビア自動免疫測定装置市場
    • 南アフリカ自動免疫測定装置市場
    • その他のラテンアメリカ・中東・アフリカの自動免疫測定装置市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • Abbott
  • Meril Life Sciences Pvt. Ltd.
  • BioMerieux
  • Arlington Scientific
  • F. Hoffmann-La Roche Ltd
  • Carolina Liquid Chemistries
  • Becton Dickinson And Company,
  • Bio-Rad Laboratories, Inc
  • PerkinElmer Inc.
  • AESKU.GROUP GmbH
目次
Product Code: A323969

The automatic immunoassay analyzer market was valued at $12.3 billion in 2023, and is projected to reach $51.4 billion by 2033, growing at a CAGR of 15.3% from 2024 to 2033.

Automatic immunoassay analyzer is an advanced medical device that performs immunoassays using antigen-antibody reactions to detect and quantify substances such as proteins, hormones, and drugs in biological samples. By automating the entire process, from sample preparation to result interpretation, these analyzers enhance efficiency, accuracy, and throughput in clinical and research settings. They are widely used in diagnostic laboratories, hospitals, and pharmaceutical industries to provide reliable and consistent results, thereby improving the speed and quality of patient care and research outcomes.

The growth of the global automatic immunoassay analyzer market is majorly driven by alarming rise in prevalence of chronic conditions such as cancer, cardiovascular diseases, and diabetes, which necessitate frequent and accurate diagnostic testing. According to a study published by the World Health Organization in September 2023, cardiovascular diseases are among the most prevalent most chronic diseases, accounting for 17.9 million deaths annually, followed by cancers with about 9.3 million deaths, and diabetes with 2.0 million deaths, including kidney disease deaths caused by diabetes. Furthermore, surge in geriatric population significantly contributes toward the market growth. This is attributed to the fact that as the population ages, there is an increased demand for diagnostic tests to monitor and manage age-related diseases, thereby boosting the market for automatic immunoassay analyzers. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. With increasing aged population, the incidence of chronic conditions is expected to rise significantly. Moreover, rise in awareness about the importance of early disease detection and preventive healthcare is leading to increased use of diagnostic tests, thus driving the demand for automatic immunoassay analyzers. Increase in trend toward personalized medicine, which requires precise and timely diagnostic information, is further accelerating the demand for reliable and high-throughput immunoassay systems. However, high initial investment and maintenance costs of advanced immunoanalyzers and need for regular maintenance, calibration, and technical support restrain the market growth. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access act as the key deterrent factors of the market. On the contrary, growing trend toward integrating immunoassay analyzers with digital health platforms and electronic health records to streamline data management and improve the overall efficiency of laboratory workflows is expected to offer lucrative opportunities for the market growth during the forecast period. Furthermore, manufacturers are focusing on developing multiplex immunoassays, which allow the simultaneous measurement of multiple biomarkers from a single sample. Such developments are anticipated to open new avenues for the market growth in the coming years.

The global automatic immunoassay analyzer market is segmented into product, application, end user, and region. On the basis of the product, the market is categorized into immunofluorescence, chemiluminescence, enzyme linked fluorescent system, and others. By application, it is classified into infectious diseases, endocrinology, drug monitoring, chronic diseases, allergy testing, and others. Depending on end user, it is divided into hospitals, diagnostic laboratories, pharmaceutical and biotechnology companies, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product, the chemiluminescence segment is expected to dominate the market from 2024 to 2033.

On the basis of application, the infectious diseases segment was the major shareholder in 2023.

Depending on end user, the pharmaceutical & biotechnology companies segment is poised for significant growth in the automatic immunoassay analyzer market in the coming years.

Region wise, automatic immunoassay analyzers are likely to gain high prominence in North America in the near future.

Competition Analysis

Competitive analysis and profiles of the major players in the global automatic immunoassay analyzer market include Abbott, Meril Life Sciences Pvt. Ltd., BioMerieux, Arlington Scientific, F. Hoffmann-La Roche Ltd, Carolina Liquid Chemistries, Becton Dickinson and Company,, Bio-Rad Laboratories, Inc, PerkinElmer Inc., and AESKU.GROUP GmbH. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Immunofluorescence
  • Chemiluminescence
  • Enzyme Linked Fluorescent System
  • Others

By Application

  • Infectious Diseases
  • Endocrinology
  • Drug Monitoring
  • Chronic Diseases
  • Allergy Testing
  • Others

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Abbott
    • Meril Life Sciences Pvt. Ltd.
    • BioMerieux
    • Arlington Scientific
    • F. Hoffmann-La Roche Ltd
    • Carolina Liquid Chemistries
    • Becton Dickinson and Company,
    • Bio-Rad Laboratories, Inc
    • PerkinElmer Inc.
    • AESKU.GROUP GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Immunofluorescence
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Chemiluminescence
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Enzyme Linked Fluorescent System
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Others
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country

CHAPTER 5: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Infectious Diseases
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Endocrinology
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Drug Monitoring
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Chronic Diseases
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Allergy Testing
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country
  • 5.7. Others
    • 5.7.1. Key Market Trends, Growth Factors and Opportunities
    • 5.7.2. Market Size and Forecast, By Region
    • 5.7.3. Market Share Analysis, By Country

CHAPTER 6: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Diagnostic Laboratories
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Pharmaceutical And Biotechnology Companies
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Others
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country

CHAPTER 7: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Automatic Immunoassay Analyzer Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Automatic Immunoassay Analyzer Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Automatic Immunoassay Analyzer Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Automatic Immunoassay Analyzer Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Automatic Immunoassay Analyzer Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Automatic Immunoassay Analyzer Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Automatic Immunoassay Analyzer Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Automatic Immunoassay Analyzer Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Automatic Immunoassay Analyzer Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Automatic Immunoassay Analyzer Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Automatic Immunoassay Analyzer Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Automatic Immunoassay Analyzer Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. Australia Automatic Immunoassay Analyzer Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Automatic Immunoassay Analyzer Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Automatic Immunoassay Analyzer Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Automatic Immunoassay Analyzer Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Automatic Immunoassay Analyzer Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Automatic Immunoassay Analyzer Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Automatic Immunoassay Analyzer Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Abbott
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Meril Life Sciences Pvt. Ltd.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. BioMerieux
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Arlington Scientific
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. F. Hoffmann-La Roche Ltd
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Carolina Liquid Chemistries
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Becton Dickinson And Company,
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Bio-Rad Laboratories, Inc
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. PerkinElmer Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. AESKU.GROUP GmbH
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments